INDUCTION OF TYPE-I DIABETES BY INTERFERON-ALPHA IN TRANSGENIC MICE

被引:262
作者
STEWART, TA [1 ]
HULTGREN, B [1 ]
HUANG, X [1 ]
PITTSMEEK, S [1 ]
HULLY, J [1 ]
MACLACHLAN, NJ [1 ]
机构
[1] UNIV CALIF DAVIS,DEPT VET PATHOL,DAVIS,CA 95616
关键词
D O I
10.1126/science.8100367
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type I diabetes is an autoimmune disease involving an interaction between an epigenetic event (possibly a viral infection), the pancreatic beta cells, and the immune system in a genetically susceptible host. The possibility that the type I interferons could mediate this interaction was tested with transgenic mice in which the insulin-producing beta cells expressed an interferon-alpha. These mice developed a hypoinsulinemic diabetes associated with a mixed inflammation centered on the islets. The inflammation and the diabetes were prevented with a neutralizing antibody to the interferon-alpha. Thus, the expression of interferon-alpha by the beta cells could be causal in the development of type I diabetes, which suggests a therapeutic approach to this disease.
引用
收藏
页码:1942 / 1946
页数:5
相关论文
共 65 条
[1]   INFLAMMATION BUT NOT AUTOIMMUNITY OCCURS IN TRANSGENIC MICE EXPRESSING CONSTITUTIVE LEVELS OF INTERLEUKIN-2 IN ISLET BETA-CELLS [J].
ALLISON, J ;
MALCOLM, L ;
CHOSICH, N ;
MILLER, JFAP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (05) :1115-1121
[2]  
APPELS B, 1989, J IMMUNOL, V142, P3803
[3]   PHARMACOKINETICS AND TISSUE DISTRIBUTION OF RECOMBINANT HUMAN ALPHA-A, ALPHA-D, ALPHA-A/D(BGL), AND I-INTERFERONS AND MOUSE ALPHA-INTERFERON IN MICE [J].
BOHOSLAWEC, O ;
TROWN, PW ;
WILLS, RJ .
JOURNAL OF INTERFERON RESEARCH, 1986, 6 (03) :207-213
[4]   THYROID AUTOIMMUNITY IN PATIENTS ON LONG-TERM THERAPY WITH LEUKOCYTE-DERIVED INTERFERON [J].
BURMAN, P ;
TOTTERMAN, TH ;
OBERG, K ;
KARLSSON, FA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (05) :1086-1090
[5]   REGULATION OF INTERLEUKIN-1 PRODUCTION BY ALPHA-INTERFERON AND BETA-INTERFERON - EVIDENCE FOR BOTH DIRECT AND INDIRECT ENHANCEMENT [J].
CANDLER, RV ;
ROUSE, BT ;
MOORE, RN .
JOURNAL OF INTERFERON RESEARCH, 1985, 5 (01) :179-189
[6]   PHARMACOKINETICS OF RECOMBINANT MURINE INTERFERON-GAMMA AND HUMAN INTERFERON-ALPHA-A/D(BGL) ADMINISTERED IN CONCERT AND THEIR INFLUENCE ON NATURAL-KILLER CELL-FUNCTION IN MICE [J].
CHEN, SA ;
SHALABY, MR ;
CRASE, DR ;
PALLADINO, MA ;
BAUGHMAN, RA .
JOURNAL OF INTERFERON RESEARCH, 1988, 8 (05) :597-608
[7]  
COLLINS AR, 1990, ADV EXP MED BIOL, V276, P497
[8]  
CONLON KC, 1990, CANCER, V65, P2237, DOI 10.1002/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO
[9]  
2-5
[10]   RESTORATION OF ANTI-INTERLEUKIN-1 DEPRESSED NATURAL-KILLER ACTIVITY BY HUMAN RECOMBINANT INTERFERON-ALPHA OR INTERFERON-GAMMA, HUMAN RECOMBINANT INTERLEUKIN-2 AND INDOMETHACIN [J].
CONTI, P ;
REALE, M ;
ANGELETTI, PU ;
DINARELLO, CA .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1988, 10 (08) :907-911